Gelteq GELS
NASDAQ GELS
$0.52 -0.02 (-3.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gelteq (GELS) Liabilities from Discontinued Operations (2023 - 2024)

Updated

Gelteq (GELS) reported Liabilities from Discontinued Operations of $13.48 million for the quarter ended Jun 30, 2024, down 6.2% from $14.37 million a year earlier.

Analysis

Gelteq (GELS) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

  • By year, Liabilities from Discontinued Operations came in at $14.37 million in the year ended Jun 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.93 Bn 34.76 Bn 1.44 Bn
2 Medpace Holdings 16.69 Bn 14.76 Bn 201.64 Mn
3 Charles River Laboratories International 13.69 Bn 12.93 Bn 363.37 Mn
4 Icon 12.39 Bn 9.50 Bn 479.29 Mn
5 Fortrea Holdings 1.84 Bn 1.22 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 795.75 Mn 33.67 Mn 18.44 Mn
7 Evotec SE 583.11 Mn -990.11 Mn -
8 Champions Oncology 67.92 Mn 43.57 Mn 7.70 Mn
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn
10 Gelteq 5.57 Mn 3.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 13.48 Mn
Jun 30, 2023 14.37 Mn
API Access

Gelteq Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=GELS&period=max&api_key=YOUR_API_KEY